Xywav FDA approval date

The FDA approved Xywav (JZP258) on 21 Jul 2020.

FDA approval date
21 Jul 2020

Drug identity checked against registry records

Also recorded as JZP258

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-07-21DayXywavFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212690", "applicant_as_listed_by_fda": "JAZZ", "brand_names": ["XYWAV"], "active_ingredients": ["CALCIUM OXYBATE", "MAGNESIUM OXYBATE", "POTASSIUM OXYBATE", "SODIUM OXYBATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200721", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026